Qi Xia

720 total citations
26 papers, 418 citations indexed

About

Qi Xia is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Qi Xia has authored 26 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Surgery and 7 papers in Oncology. Recurrent topics in Qi Xia's work include Bladder and Urothelial Cancer Treatments (6 papers), Fibroblast Growth Factor Research (5 papers) and Acute Myeloid Leukemia Research (3 papers). Qi Xia is often cited by papers focused on Bladder and Urothelial Cancer Treatments (6 papers), Fibroblast Growth Factor Research (5 papers) and Acute Myeloid Leukemia Research (3 papers). Qi Xia collaborates with scholars based in United States, Germany and China. Qi Xia's co-authors include Harry A. Drabkin, Ronald M. Bukowski, Ulka N. Vaishampayan, Janice Dutcher, Frank A. Scappaticci, Fairooz F. Kabbinavar, Robert A. Figlin, Sandy Srinivas, Keith T. Flaherty and David F. McDermott and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Qi Xia

22 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qi Xia United States 9 216 206 134 122 82 26 418
Eugenio Fiorentino Italy 15 156 0.7× 209 1.0× 177 1.3× 149 1.2× 176 2.1× 41 572
Shinichi Asaka Japan 12 111 0.5× 175 0.8× 96 0.7× 161 1.3× 109 1.3× 58 462
David Saavedra-Pérez Spain 9 163 0.8× 94 0.5× 142 1.1× 276 2.3× 149 1.8× 29 580
Jamie Weaver United Kingdom 12 107 0.5× 83 0.4× 105 0.8× 109 0.9× 98 1.2× 35 361
Keum Ha Choi South Korea 13 122 0.6× 137 0.7× 112 0.8× 134 1.1× 107 1.3× 48 443
L. Wood United States 12 333 1.5× 254 1.2× 126 0.9× 185 1.5× 25 0.3× 23 481
Marco Stellato Italy 10 229 1.1× 87 0.4× 82 0.6× 206 1.7× 101 1.2× 43 408
J. Mazurka Canada 10 85 0.4× 167 0.8× 45 0.3× 120 1.0× 47 0.6× 15 488
Keita Uchino Japan 12 151 0.7× 86 0.4× 39 0.3× 215 1.8× 59 0.7× 40 357
Amar Mahgoub United States 9 62 0.3× 113 0.5× 91 0.7× 88 0.7× 158 1.9× 18 401

Countries citing papers authored by Qi Xia

Since Specialization
Citations

This map shows the geographic impact of Qi Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Xia more than expected).

Fields of papers citing papers by Qi Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Xia. The network helps show where Qi Xia may publish in the future.

Co-authorship network of co-authors of Qi Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Qi Xia. A scholar is included among the top collaborators of Qi Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi Xia. Qi Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Triantos, Spyros, Shibu Thomas, Qi Xia, et al.. (2025). Prognostic Impact of Oncogenic Fibroblast Growth Factor Receptor Alterations in Patients With Advanced Solid Tumors in a Real‐World Setting. Cancer Medicine. 14(4). e70546–e70546.
2.
Wang, Guowei, Ruiquan Liao, Lijuan Huang, et al.. (2024). Study of the flow pattern and pressure drop law of the air-water-foam three-phase flow. Experimental Thermal and Fluid Science. 155. 111207–111207. 1 indexed citations
3.
Xia, Qi. (2024). Prognostic factors in postoperative patients with cutaneous melanoma: a systematic review and meta-analysis. American Journal of Cancer Research. 14(5). 1947–1956. 2 indexed citations
4.
Li, Zhi, et al.. (2024). MDSCs in bone metastasis: Mechanisms and therapeutic potential. Cancer Letters. 592. 216906–216906. 7 indexed citations
5.
Wu, Na, et al.. (2023). A novel reconstruction strategy in esophagectomy for megaesophagus. JTCVS Techniques. 22. 307–311.
6.
Xia, Qi, et al.. (2023). CFD Numerical Simulation Study Based on Plunger Air Lift. Processes. 11(11). 3103–3103.
7.
8.
9.
Moreno, Víctor, Ruth Perets, Nele Fourneau, et al.. (2022). A phase 1 study of intravenous mitazalimab, a CD40 agonistic monoclonal antibody, in patients with advanced solid tumors. Investigational New Drugs. 41(1). 93–104. 18 indexed citations
10.
Kuykendall, Andrew, Libo Sun, John Mascarenhas, et al.. (2021). Favorable overall survival with imetelstat in relapsed/refractory myelofibrosis patients compared with real-world data. Annals of Hematology. 101(1). 139–146. 18 indexed citations
11.
Massard, Christophe, Shubham Pant, Gopa Iyer, et al.. (2021). Preliminary results of molecular screening for FGFR alterations (alts) in the RAGNAR histology-agnostic study with the FGFR-inhibitor (FGFRi) erdafitinib.. Journal of Clinical Oncology. 39(15_suppl). 4081–4081. 2 indexed citations
12.
Kim, William Y., Tracy L. Rose, Florian Roghmann, et al.. (2020). Predictive value of fibroblast growth factor receptor (FGFR) alterations on anti-PD-(L)1 treatment outcomes in patients (Pts) with advanced urothelial cancer (UC): Pooled analysis of real-world data.. Journal of Clinical Oncology. 38(6_suppl). 493–493. 4 indexed citations
13.
Morley, Roland, Peter G. Hawkins, Y. Suzuki, et al.. (2015). Safety of Onartuzumab in Patients with Solid Tumors: Experience to Date from the Onartuzumab Clinical Trial Program. PLoS ONE. 10(10). e0139679–e0139679. 18 indexed citations
14.
Akerley, Wallace, John D. Hainsworth, Yun Oh, et al.. (2007). PD3-3-3: Safety of bevacizumab therapy in subjects with brain metastases due to non-small cell lung cancer (NSCLC). Journal of Thoracic Oncology. 2(8). S467–S467. 7 indexed citations
15.
Xia, Qi & Donald R. Hoover. (2007). A Procedure for Group Sequential Comparative Poisson Trials. Journal of Biopharmaceutical Statistics. 17(5). 869–881. 4 indexed citations
16.
Bukowski, Ronald M., Fairooz F. Kabbinavar, Robert A. Figlin, et al.. (2007). Randomized Phase II Study of Erlotinib Combined With Bevacizumab Compared With Bevacizumab Alone in Metastatic Renal Cell Cancer. Journal of Clinical Oncology. 25(29). 4536–4541. 231 indexed citations
17.
Chang, Victor T., Qi Xia, & Basil Kasimis. (2005). The Functional Assessment of Anorexia/Cachexia Therapy (FAACT) Appetite Scale in veteran cancer patients.. PubMed. 3(5). 377–82. 29 indexed citations
18.
Tung, H. N., et al.. (1991). Hypertrophic smooth muscle in the partially obstructed opossum esophagus. Gastroenterology. 100(4). 853–864. 37 indexed citations
19.
See, William A., et al.. (1991). A Continuous Intravesical Drug Delivery System for the Rat. The Journal of Urology. 145(3). 596–599. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eugenio Fiorentino Breakdown of academic impact, for papers by Shinichi Asaka Breakdown of academic impact, for papers by David Saavedra-Pérez Breakdown of academic impact, for papers by Jamie Weaver Breakdown of academic impact, for papers by Keum Ha Choi Breakdown of academic impact, for papers by L. Wood Breakdown of academic impact, for papers by Marco Stellato Breakdown of academic impact, for papers by J. Mazurka Breakdown of academic impact, for papers by Keita Uchino Breakdown of academic impact, for papers by Amar Mahgoub
Rankless by CCL
2026